Brind.

CDC reported US overdose death trends and expanding naloxone access, while Emergent BioSolutions acquired rights to KLOXXADO in Canada.

1 report, 0 independent Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

CDC reported US overdose death trends and expanding naloxone access, while Emergent BioSolutions acquired rights to KLOXXADO in Canada.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Emergent BioSolutions is facing increased competition and pricing pressure in the naloxone market while undergoing restructuring and accelerating government deliveries.Sub-event
  2. US overdose trends reported; naloxone access expanding and KLOXXADO rights acquired in Canada.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Unknown outlet